BMRN   $63.94  -1.75% Market Closed After Close 63.94 0.0

BioMarin Pharmaceutical Inc.

EMA (20): 2026-09-15 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

EMA (50): 2026-06-22 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-06-22 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

Trend Type flat and up
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield 0.98%
EMA (20) date of signal Sept. 15, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 16.42%
EMA (50) date of signal June 22, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 16.42%
EMA (100) date of signal June 22, 2026, 3 a.m.
RSI Signals bullish
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 17, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield 0.98%
MACD date of signal Sept. 15, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 0.0
Stochastic date of signal Sept. 17, 2026, 3 a.m.
Updated Sept. 18, 2026, 11 p.m.